患者对慢性鼻炎疾病控制的国际多学科共识标准的看法
Ryan A Cotter1, Firas A Houssein1, Rebecca K Reinert1
1Department of Otolaryngology-Head and Neck Surgery University of Cincinnati College of Medicine Cincinnati Ohio USA.
Laryngoscope investigative otolaryngology
|September 16, 2024
概括
慢性鼻炎 (CRS) 患者通常同意已建立的疾病控制标准,但强调需要包括面部疼痛/压力. 患者的观点对于解释这些标准至关重要.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 患者报告的结果
- 鼻疾病研究 鼻疾病研究
背景情况:
- 一个国际小组建立了共识和接近共识的标准来评估慢性鼻炎 (CRS) 疾病控制.
- 了解患者对这些标准的看法对于其临床应用至关重要.
研究的目的:
- 评估慢性鼻炎患者如何看待最近确定的疾病控制共识和接近共识标准.
- 将患者的见解纳入CRS疾病控制指标的解释和潜在改进中.
主要方法:
- 进行了一项定性现象学研究.
- 与各种慢性鼻炎患者进行了21次半结构面试.
- 采访成绩单使用常量比较方法分析,以确定反复出现的主题.
主要成果:
- 患者在很大程度上同意共识标准 (症状严重程度,阻碍,自我评估控制,皮质类固醇需求).
- 大多数患者符合几乎一致的标准 (内镜检查,嗅觉,排水,日常活动受损,生活质量).
- 一个重要的主题是需要添加面部疼痛/压力标准,在包括所有病因的嗅觉丧失方面存在一些分歧.
结论:
- 慢性鼻炎患者肯定了已建立的共识和接近共识的标准.
- 患者强烈主张将面部疼痛/压力作为关键标准.
- 在解释CRS疾病控制标准时,应考虑以患者为中心的反.
相关概念视频
Chronic Pharyngitis
1.4K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
1.4K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.7K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.7K
Cystic Fibrosis: Management
146
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
146
COPD: Management Using Bronchodilators and Corticosteroids
188
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
188
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Drugs Used in Lower Respiratory Disorders: Overview
362
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
362


